Glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) may promote bone formation, but conversely, they could also weaken bones due to the reduction in mechanical load associated with weight loss. However, the clinical… Click to show full abstract
Glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) may promote bone formation, but conversely, they could also weaken bones due to the reduction in mechanical load associated with weight loss. However, the clinical effects in humans have not been clearly demonstrated. This meta‐analysis aimed to evaluate whether GLP‐1RAs affect BMD and bone turnover markers.
Keywords:
meta analysis;
like peptide;
receptor agonist;
peptide receptor;
bone;
glucagon like
Journal Title: Diabetes/Metabolism Research and Reviews
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Diabetes/Metabolism Research and Reviews
Year Published: 2024
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!